Gene Symbol | Gene ID | Gene Info |
---|---|---|
Id4
|
ENSMUSG00000021379.1 | inhibitor of DNA binding 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_48259532_48259998 | Id4 | 1463 | 0.277996 | 0.41 | 1.2e-03 | Click! |
chr13_48261032_48261213 | Id4 | 106 | 0.924578 | -0.19 | 1.5e-01 | Click! |
chr13_48260364_48260729 | Id4 | 682 | 0.531483 | 0.08 | 5.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_34125172_34126139 | 9.47 |
Tubb2b |
tubulin, beta 2B class IIB |
4699 |
0.12 |
chr13_83716978_83717166 | 9.21 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
4309 |
0.15 |
chr8_121730928_121732115 | 9.10 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr8_125897868_125898882 | 7.81 |
Pcnx2 |
pecanex homolog 2 |
58 |
0.88 |
chr7_18926045_18927019 | 7.73 |
Nova2 |
NOVA alternative splicing regulator 2 |
644 |
0.54 |
chr19_60468285_60469063 | 7.72 |
Prlhr |
prolactin releasing hormone receptor |
370 |
0.9 |
chr8_123412815_123413352 | 7.65 |
Tubb3 |
tubulin, beta 3 class III |
1493 |
0.18 |
chr7_6414737_6415889 | 7.60 |
Smim17 |
small integral membrane protein 17 |
138 |
0.89 |
chr3_34560367_34561122 | 7.49 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
352 |
0.85 |
chr5_120430812_120431653 | 7.42 |
Lhx5 |
LIM homeobox protein 5 |
467 |
0.48 |
chr17_91093132_91093621 | 7.32 |
Nrxn1 |
neurexin I |
305 |
0.87 |
chr3_31309226_31310664 | 6.96 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr19_7421074_7423945 | 6.93 |
Mir6991 |
microRNA 6991 |
64 |
0.94 |
chr15_76519928_76521866 | 6.92 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr4_156184450_156185176 | 6.77 |
Agrn |
agrin |
1088 |
0.33 |
chr6_136170568_136170996 | 6.75 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1107 |
0.5 |
chr13_57907102_57908323 | 6.70 |
Spock1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 |
125 |
0.98 |
chr2_180890379_180892235 | 6.66 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr3_88208231_88208654 | 6.60 |
Gm3764 |
predicted gene 3764 |
1030 |
0.28 |
chr8_70119024_70120981 | 6.51 |
Ncan |
neurocan |
871 |
0.35 |
chr14_52008166_52009757 | 6.49 |
Zfp219 |
zinc finger protein 219 |
1285 |
0.23 |
chr19_41742559_41744061 | 6.48 |
Slit1 |
slit guidance ligand 1 |
176 |
0.96 |
chr15_25754177_25754669 | 6.46 |
Myo10 |
myosin X |
1444 |
0.48 |
chr2_178141581_178143125 | 6.42 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr13_105444000_105445296 | 6.35 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
1009 |
0.69 |
chr2_114012816_114014272 | 6.27 |
A530058N18Rik |
RIKEN cDNA A530058N18 gene |
19 |
0.54 |
chr18_72949070_72949855 | 6.19 |
Gm31908 |
predicted gene, 31908 |
28372 |
0.23 |
chr1_136132801_136134260 | 5.96 |
Kif21b |
kinesin family member 21B |
2076 |
0.19 |
chr17_52600782_52601825 | 5.95 |
Gm27217 |
predicted gene 27217 |
1357 |
0.38 |
chr13_83722440_83722673 | 5.88 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1175 |
0.38 |
chr3_94479508_94480443 | 5.64 |
Riiad1 |
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
366 |
0.63 |
chr12_53250672_53251038 | 5.62 |
Npas3 |
neuronal PAS domain protein 3 |
2170 |
0.43 |
chr2_25318080_25319601 | 5.60 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
255 |
0.77 |
chr12_88724589_88725423 | 5.59 |
Nrxn3 |
neurexin III |
3 |
0.98 |
chr15_72806569_72807700 | 5.56 |
Peg13 |
paternally expressed 13 |
3190 |
0.32 |
chr1_42689823_42691041 | 5.53 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
2661 |
0.19 |
chr12_110187430_110189676 | 5.49 |
Gm34785 |
predicted gene, 34785 |
492 |
0.73 |
chr17_15370150_15371313 | 5.47 |
Dll1 |
delta like canonical Notch ligand 1 |
1100 |
0.46 |
chr7_28301100_28302593 | 5.46 |
Dll3 |
delta like canonical Notch ligand 3 |
74 |
0.93 |
chr4_150651111_150652374 | 5.43 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr13_49145336_49145849 | 5.39 |
Wnk2 |
WNK lysine deficient protein kinase 2 |
1640 |
0.4 |
chr6_37642279_37643109 | 5.36 |
Ybx1-ps2 |
Y box protein 1, pseudogene 2 |
44501 |
0.17 |
chr7_79498955_79500626 | 5.36 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr11_33202043_33204837 | 5.34 |
Tlx3 |
T cell leukemia, homeobox 3 |
149 |
0.86 |
chr5_112225574_112226319 | 5.32 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
2695 |
0.17 |
chr5_135806693_135807939 | 5.31 |
Srrm3 |
serine/arginine repetitive matrix 3 |
419 |
0.73 |
chr6_127766683_127768449 | 5.28 |
Gm42738 |
predicted gene 42738 |
24 |
0.95 |
chr11_21995570_21998947 | 5.28 |
Otx1 |
orthodenticle homeobox 1 |
4357 |
0.28 |
chr11_115366861_115367995 | 5.24 |
Hid1 |
HID1 domain containing |
181 |
0.88 |
chr17_52602081_52603198 | 5.18 |
Gm27217 |
predicted gene 27217 |
21 |
0.54 |
chr19_45230983_45235468 | 5.09 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr4_32862939_32864770 | 5.07 |
Ankrd6 |
ankyrin repeat domain 6 |
3171 |
0.24 |
chr12_117692658_117693268 | 5.06 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
4007 |
0.27 |
chr14_89230146_89230746 | 5.06 |
Gm36946 |
predicted gene, 36946 |
120579 |
0.06 |
chr3_88214322_88216234 | 5.04 |
Mir3093 |
microRNA 3093 |
107 |
0.63 |
chr12_11881634_11882192 | 4.98 |
Tubb2a-ps2 |
tubulin, beta 2a, pseudogene 2 |
750 |
0.71 |
chr10_81229656_81230911 | 4.97 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr1_134075582_134077148 | 4.91 |
Btg2 |
BTG anti-proliferation factor 2 |
2755 |
0.19 |
chr2_26485135_26488628 | 4.90 |
Notch1 |
notch 1 |
16383 |
0.09 |
chr7_87584098_87584781 | 4.90 |
Grm5 |
glutamate receptor, metabotropic 5 |
41 |
0.99 |
chr11_67596613_67596872 | 4.89 |
Gas7 |
growth arrest specific 7 |
168 |
0.96 |
chr1_81077232_81078427 | 4.87 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr3_88208985_88210116 | 4.85 |
Gm3764 |
predicted gene 3764 |
78 |
0.92 |
chr8_94995272_94995731 | 4.83 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
160 |
0.93 |
chr2_152081612_152083149 | 4.83 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr7_79507205_79507895 | 4.82 |
Mir9-3 |
microRNA 9-3 |
2286 |
0.14 |
chrX_7921647_7923257 | 4.81 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
2630 |
0.1 |
chr6_8952771_8953600 | 4.76 |
Nxph1 |
neurexophilin 1 |
3509 |
0.38 |
chr11_116920303_116921024 | 4.74 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
1800 |
0.3 |
chr5_75075112_75077490 | 4.68 |
Gsx2 |
GS homeobox 2 |
699 |
0.56 |
chr11_71750709_71751963 | 4.60 |
Wscd1 |
WSC domain containing 1 |
40 |
0.97 |
chrX_105390628_105392456 | 4.60 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr5_131531462_131532675 | 4.58 |
Auts2 |
autism susceptibility candidate 2 |
2329 |
0.29 |
chr2_165367693_165368982 | 4.56 |
Zfp663 |
zinc finger protein 663 |
386 |
0.8 |
chr8_94152224_94153713 | 4.53 |
Mt3 |
metallothionein 3 |
222 |
0.87 |
chr2_52557337_52558561 | 4.53 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr6_39871435_39873403 | 4.53 |
Gm26833 |
predicted gene, 26833 |
448 |
0.58 |
chr13_97245763_97246942 | 4.51 |
Enc1 |
ectodermal-neural cortex 1 |
5247 |
0.18 |
chr10_11080290_11081200 | 4.46 |
Grm1 |
glutamate receptor, metabotropic 1 |
211 |
0.95 |
chr19_6499251_6500132 | 4.46 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr8_41052368_41053980 | 4.44 |
Gm16193 |
predicted gene 16193 |
64 |
0.96 |
chr1_75277211_75278430 | 4.44 |
Resp18 |
regulated endocrine-specific protein 18 |
464 |
0.62 |
chr9_106147912_106149765 | 4.40 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr13_83722679_83723219 | 4.40 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1568 |
0.29 |
chr8_4216103_4217573 | 4.38 |
Prr36 |
proline rich 36 |
74 |
0.93 |
chr19_6500236_6500453 | 4.38 |
Nrxn2 |
neurexin II |
2509 |
0.18 |
chr6_48537635_48538183 | 4.38 |
Atp6v0e2 |
ATPase, H+ transporting, lysosomal V0 subunit E2 |
244 |
0.61 |
chr8_124792307_124794543 | 4.37 |
Trim67 |
tripartite motif-containing 67 |
333 |
0.82 |
chr4_134357022_134358132 | 4.35 |
Extl1 |
exostosin-like glycosyltransferase 1 |
7847 |
0.11 |
chr7_142091808_142093330 | 4.35 |
Dusp8 |
dual specificity phosphatase 8 |
2703 |
0.11 |
chr2_126552518_126553853 | 4.34 |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
405 |
0.86 |
chr2_79455488_79456190 | 4.32 |
Neurod1 |
neurogenic differentiation 1 |
912 |
0.42 |
chr13_83732205_83734272 | 4.30 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr18_31446492_31447667 | 4.28 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr4_9269280_9270516 | 4.28 |
Clvs1 |
clavesin 1 |
551 |
0.81 |
chr14_32600992_32601704 | 4.25 |
Prrxl1 |
paired related homeobox protein-like 1 |
1390 |
0.39 |
chr2_25580658_25582212 | 4.22 |
Ajm1 |
apical junction component 1 |
293 |
0.72 |
chr19_47019038_47019748 | 4.21 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
4240 |
0.14 |
chr10_41071491_41071917 | 4.19 |
Gpr6 |
G protein-coupled receptor 6 |
581 |
0.7 |
chr2_25264308_25268001 | 4.19 |
Tprn |
taperin |
1410 |
0.14 |
chr6_28829740_28830660 | 4.18 |
Lrrc4 |
leucine rich repeat containing 4 |
145 |
0.96 |
chr17_31295981_31297202 | 4.17 |
Gm8437 |
predicted gene 8437 |
98 |
0.67 |
chr8_123333823_123334660 | 4.16 |
Spire2 |
spire type actin nucleation factor 2 |
1528 |
0.22 |
chr15_87545474_87545628 | 4.16 |
Tafa5 |
TAFA chemokine like family member 5 |
1252 |
0.64 |
chr12_117688775_117690161 | 4.16 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
512 |
0.83 |
chr14_64591036_64591686 | 4.15 |
Mir3078 |
microRNA 3078 |
176 |
0.84 |
chr3_88211471_88212561 | 4.15 |
Gm3764 |
predicted gene 3764 |
2469 |
0.11 |
chr7_44336079_44337576 | 4.14 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr9_58197310_58202560 | 4.13 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr5_107498136_107498752 | 4.10 |
Btbd8 |
BTB (POZ) domain containing 8 |
665 |
0.57 |
chr11_106019908_106020882 | 4.09 |
Kcnh6 |
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
6622 |
0.1 |
chr13_54765549_54766801 | 4.08 |
Sncb |
synuclein, beta |
78 |
0.95 |
chr2_172040251_172043672 | 4.08 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr1_124045018_124046369 | 4.07 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr4_25797148_25797299 | 4.05 |
Fut9 |
fucosyltransferase 9 |
2632 |
0.27 |
chr13_54951042_54951756 | 4.01 |
Unc5a |
unc-5 netrin receptor A |
1988 |
0.26 |
chr7_98193340_98194780 | 4.01 |
B3gnt6 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) |
5421 |
0.16 |
chr13_83715222_83716973 | 3.99 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr9_42121573_42122781 | 3.99 |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
2120 |
0.33 |
chr13_105249326_105250833 | 3.96 |
Rnf180 |
ring finger protein 180 |
20960 |
0.22 |
chr14_103652148_103652299 | 3.92 |
Slain1 |
SLAIN motif family, member 1 |
1577 |
0.33 |
chr5_114570797_114571175 | 3.92 |
Fam222a |
family with sequence similarity 222, member A |
2969 |
0.22 |
chr3_45379351_45381850 | 3.91 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chr13_20474951_20475127 | 3.90 |
Gm32036 |
predicted gene, 32036 |
1549 |
0.33 |
chr3_84219260_84219630 | 3.87 |
Trim2 |
tripartite motif-containing 2 |
1400 |
0.49 |
chr3_17793835_17795104 | 3.87 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr6_37297951_37298469 | 3.87 |
Dgki |
diacylglycerol kinase, iota |
1427 |
0.53 |
chr7_109165724_109166870 | 3.86 |
Lmo1 |
LIM domain only 1 |
4215 |
0.21 |
chr9_110726580_110727690 | 3.86 |
Myl3 |
myosin, light polypeptide 3 |
14726 |
0.1 |
chr10_80130019_80132981 | 3.84 |
Cbarp |
calcium channel, voltage-dependent, beta subunit associated regulatory protein |
3181 |
0.11 |
chr12_111668601_111669956 | 3.83 |
Ckb |
creatine kinase, brain |
2207 |
0.17 |
chr7_93082007_93082946 | 3.82 |
Gm9934 |
predicted gene 9934 |
1449 |
0.36 |
chr6_134886327_134886478 | 3.81 |
Gpr19 |
G protein-coupled receptor 19 |
1366 |
0.28 |
chrX_143666970_143667372 | 3.81 |
Pak3 |
p21 (RAC1) activated kinase 3 |
1426 |
0.57 |
chr6_114282516_114283979 | 3.81 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr4_129226645_129228191 | 3.81 |
C77080 |
expressed sequence C77080 |
62 |
0.96 |
chr10_81472751_81473777 | 3.80 |
Celf5 |
CUGBP, Elav-like family member 5 |
114 |
0.9 |
chr4_137728594_137729648 | 3.79 |
Rap1gap |
Rap1 GTPase-activating protein |
910 |
0.56 |
chr6_54564534_54565307 | 3.79 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr2_57111288_57112991 | 3.78 |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
933 |
0.6 |
chr14_111672564_111672912 | 3.78 |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
2359 |
0.33 |
chr9_107401822_107402928 | 3.77 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
2306 |
0.19 |
chr4_140244024_140245271 | 3.77 |
Igsf21 |
immunoglobulin superfamily, member 21 |
2137 |
0.36 |
chr3_68573207_68574269 | 3.72 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr2_157917276_157917700 | 3.72 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
2835 |
0.27 |
chr3_88217669_88217857 | 3.70 |
Gm25641 |
predicted gene, 25641 |
2067 |
0.12 |
chr6_116055796_116056221 | 3.70 |
Tmcc1 |
transmembrane and coiled coil domains 1 |
947 |
0.55 |
chr18_34840357_34841683 | 3.69 |
Reep2 |
receptor accessory protein 2 |
431 |
0.77 |
chr1_42699114_42699733 | 3.69 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
3655 |
0.16 |
chr19_6498687_6498960 | 3.69 |
Nrxn2 |
neurexin II |
988 |
0.42 |
chr16_77420100_77420782 | 3.69 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
1379 |
0.28 |
chr11_57013425_57013750 | 3.69 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
541 |
0.88 |
chr18_60925301_60926809 | 3.68 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr13_109442519_109443753 | 3.67 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr1_194623571_194625393 | 3.67 |
Plxna2 |
plexin A2 |
4657 |
0.21 |
chr1_132541040_132543287 | 3.66 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr14_39471112_39471496 | 3.63 |
Nrg3 |
neuregulin 3 |
1362 |
0.61 |
chr3_8509825_8511666 | 3.62 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr10_57631719_57633022 | 3.62 |
Pkib |
protein kinase inhibitor beta, cAMP dependent, testis specific |
246 |
0.94 |
chr2_19429906_19432521 | 3.60 |
Gm13344 |
predicted gene 13344 |
770 |
0.52 |
chr6_91409540_91411888 | 3.59 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
649 |
0.42 |
chr4_36953759_36954250 | 3.59 |
Gm12371 |
predicted gene 12371 |
1038 |
0.55 |
chr1_172056022_172057415 | 3.58 |
Nhlh1 |
nescient helix loop helix 1 |
855 |
0.45 |
chr6_119479570_119481166 | 3.57 |
Fbxl14 |
F-box and leucine-rich repeat protein 14 |
700 |
0.7 |
chr2_181768465_181769553 | 3.56 |
Myt1 |
myelin transcription factor 1 |
1497 |
0.33 |
chr9_52677837_52678041 | 3.56 |
AI593442 |
expressed sequence AI593442 |
1490 |
0.37 |
chr3_34659833_34662467 | 3.55 |
Gm42693 |
predicted gene 42693 |
3139 |
0.15 |
chr12_118848802_118850409 | 3.55 |
Sp8 |
trans-acting transcription factor 8 |
2019 |
0.36 |
chr5_120431744_120433119 | 3.55 |
Gm27199 |
predicted gene 27199 |
664 |
0.41 |
chr11_6598568_6599983 | 3.55 |
Nacad |
NAC alpha domain containing |
117 |
0.92 |
chr7_79501250_79502506 | 3.55 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr2_22623043_22623993 | 3.54 |
Gad2 |
glutamic acid decarboxylase 2 |
214 |
0.91 |
chr16_18129524_18129878 | 3.54 |
Rtn4r |
reticulon 4 receptor |
2059 |
0.22 |
chr9_110051810_110053856 | 3.53 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr10_57784547_57786586 | 3.52 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr11_80482715_80483407 | 3.52 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
6005 |
0.19 |
chr7_141949754_141950818 | 3.51 |
Brsk2 |
BR serine/threonine kinase 2 |
200 |
0.83 |
chr2_105668422_105670370 | 3.51 |
Pax6 |
paired box 6 |
461 |
0.65 |
chr11_61453075_61454398 | 3.49 |
Rnf112 |
ring finger protein 112 |
183 |
0.92 |
chr15_89532557_89533956 | 3.49 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
366 |
0.78 |
chr17_56241459_56242409 | 3.49 |
A230051N06Rik |
RIKEN cDNA A230051N06 gene |
218 |
0.81 |
chrX_110817183_110817473 | 3.47 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
3048 |
0.3 |
chrX_101301762_101302890 | 3.47 |
Nlgn3 |
neuroligin 3 |
1852 |
0.2 |
chr6_119328752_119331284 | 3.47 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
739 |
0.43 |
chr4_155042413_155043778 | 3.46 |
Plch2 |
phospholipase C, eta 2 |
59 |
0.94 |
chr4_49061590_49062325 | 3.45 |
Plppr1 |
phospholipid phosphatase related 1 |
2501 |
0.38 |
chr10_80300884_80302968 | 3.45 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr4_25797578_25797990 | 3.43 |
Fut9 |
fucosyltransferase 9 |
2071 |
0.32 |
chr1_72536044_72537425 | 3.41 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
196 |
0.95 |
chr1_135248312_135249161 | 3.41 |
Gm26642 |
predicted gene, 26642 |
175 |
0.91 |
chr17_91090702_91091377 | 3.38 |
Nrxn1 |
neurexin I |
1694 |
0.28 |
chr2_181598307_181599468 | 3.38 |
Samd10 |
sterile alpha motif domain containing 10 |
311 |
0.76 |
chr3_84302497_84302941 | 3.37 |
Trim2 |
tripartite motif-containing 2 |
2022 |
0.41 |
chr10_93275719_93277211 | 3.37 |
Elk3 |
ELK3, member of ETS oncogene family |
34346 |
0.13 |
chr11_36675585_36676180 | 3.37 |
Tenm2 |
teneurin transmembrane protein 2 |
1863 |
0.47 |
chr12_113141740_113143605 | 3.36 |
Crip2 |
cysteine rich protein 2 |
136 |
0.92 |
chr1_5023504_5023905 | 3.36 |
Rgs20 |
regulator of G-protein signaling 20 |
4165 |
0.2 |
chr6_48538201_48538374 | 3.35 |
Atp6v0e2 |
ATPase, H+ transporting, lysosomal V0 subunit E2 |
622 |
0.37 |
chr1_143644977_143645827 | 3.34 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
2877 |
0.24 |
chr4_115133068_115134495 | 3.34 |
Cyp4x1os |
cytochrome P450, family 4, subfamily x, polypeptide 1, opposite strand |
51 |
0.69 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 17.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
3.6 | 10.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.0 | 8.9 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
2.3 | 6.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.2 | 15.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
2.1 | 8.6 | GO:0046959 | habituation(GO:0046959) |
1.9 | 5.8 | GO:0021586 | pons maturation(GO:0021586) |
1.9 | 5.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.8 | 7.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.8 | 5.3 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.7 | 17.1 | GO:0071625 | vocalization behavior(GO:0071625) |
1.7 | 6.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.6 | 19.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.6 | 6.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.5 | 6.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.5 | 3.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.5 | 4.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.4 | 11.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.4 | 7.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.4 | 5.6 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.4 | 2.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.3 | 7.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
1.3 | 3.9 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.2 | 1.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.2 | 2.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.2 | 3.6 | GO:0008050 | female courtship behavior(GO:0008050) |
1.2 | 3.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.2 | 1.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.1 | 4.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.1 | 5.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 14.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
1.1 | 8.7 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.1 | 5.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.1 | 5.3 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.0 | 3.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.0 | 3.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.0 | 1.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.0 | 3.0 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.0 | 2.9 | GO:0015817 | histidine transport(GO:0015817) |
1.0 | 2.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.0 | 7.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.0 | 7.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.9 | 5.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.9 | 2.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.9 | 2.8 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.9 | 8.5 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.9 | 1.9 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.9 | 1.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.9 | 1.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.9 | 17.5 | GO:0001964 | startle response(GO:0001964) |
0.9 | 1.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.9 | 2.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.9 | 6.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.9 | 0.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.9 | 2.6 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.9 | 2.6 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.9 | 1.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 2.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 4.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.8 | 3.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.8 | 7.1 | GO:0007614 | short-term memory(GO:0007614) |
0.8 | 2.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.8 | 3.1 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.8 | 1.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.8 | 0.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.7 | 2.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.7 | 2.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 0.7 | GO:0048880 | sensory system development(GO:0048880) |
0.7 | 0.7 | GO:2000974 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.7 | 3.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.7 | 3.7 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.7 | 2.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.7 | 5.8 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.7 | 3.6 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.7 | 5.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 1.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.7 | 5.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 2.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.7 | 3.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.7 | 2.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.7 | 1.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 2.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 2.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.7 | 0.7 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.7 | 0.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.7 | 2.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.7 | 3.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.7 | 10.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.6 | 1.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 5.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.6 | 7.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 | 3.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.6 | 1.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 0.6 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.6 | 3.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 1.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.6 | 1.2 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.6 | 3.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.6 | 2.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 2.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.6 | 2.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 3.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.6 | 1.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 1.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 3.4 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 1.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 1.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.6 | 3.3 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.5 | 2.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.5 | 1.1 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 1.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 2.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 1.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.5 | 1.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 3.6 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.5 | 4.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 1.5 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.5 | 4.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.5 | 1.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 3.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 2.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 1.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.5 | 10.7 | GO:0007616 | long-term memory(GO:0007616) |
0.5 | 1.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 9.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 3.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 8.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 0.5 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 0.9 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 0.5 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.5 | 1.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.5 | 3.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.5 | 0.9 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.8 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 0.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 2.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.4 | 1.3 | GO:0015747 | urate transport(GO:0015747) |
0.4 | 3.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 2.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 1.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 5.2 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.4 | 1.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 5.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.4 | 4.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 2.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.4 | 2.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 3.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.4 | 1.7 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.4 | 1.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.4 | 0.8 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 0.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.4 | 2.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 4.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.4 | 6.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 2.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 2.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 0.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 1.6 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 1.2 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 0.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.4 | 4.4 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 1.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 0.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 0.8 | GO:0035793 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 0.4 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.4 | 1.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.4 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 1.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.4 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 3.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 1.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 1.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 1.9 | GO:0021854 | hypothalamus development(GO:0021854) |
0.4 | 0.7 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.4 | 3.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 1.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.4 | 1.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 2.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.4 | 1.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.4 | 1.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 3.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 0.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 1.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 0.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 0.7 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.4 | 0.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.3 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.3 | 4.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.3 | 0.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 0.3 | GO:0046958 | nonassociative learning(GO:0046958) |
0.3 | 0.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.3 | 6.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 3.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.3 | 1.0 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.3 | 3.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 3.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 1.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 2.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 3.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 1.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 1.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 2.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 1.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 1.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 0.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 4.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.3 | 0.6 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.3 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 2.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 1.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 4.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 13.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 0.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 11.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 0.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 1.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 1.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 0.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 2.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.3 | 9.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 0.6 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 0.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 1.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.3 | 17.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 2.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 0.3 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 2.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 1.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.4 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.3 | 1.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 0.6 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 1.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.3 | 0.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 0.3 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.3 | 5.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.8 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.3 | 2.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.3 | 0.3 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.3 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 1.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 0.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.5 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 0.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 2.3 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 1.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 3.0 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 4.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 1.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 2.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 0.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 1.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 1.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.5 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.7 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 2.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 8.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 1.2 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.2 | 0.9 | GO:0015824 | proline transport(GO:0015824) |
0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 1.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.2 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.2 | 0.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.2 | 1.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 1.8 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 1.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.2 | 5.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 0.7 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.2 | GO:1902837 | amino acid import into cell(GO:1902837) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 2.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.4 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.2 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 3.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 1.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.2 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 1.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.2 | 0.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 4.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 1.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.6 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 20.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.6 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.2 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 2.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 1.8 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.4 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.2 | 3.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.2 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.6 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 11.6 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.2 | 0.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 0.8 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.2 | 1.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.8 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 2.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.2 | 1.1 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 3.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.4 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.2 | 0.4 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.2 | 0.2 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.2 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 2.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 2.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 1.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 1.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.2 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 0.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.2 | GO:1903899 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.7 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 3.6 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.6 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.2 | 0.5 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.2 | 1.6 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.3 | GO:0015810 | aspartate transport(GO:0015810) |
0.2 | 0.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.8 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.6 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.2 | 0.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.3 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.2 | 0.6 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.6 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.4 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 1.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.6 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.4 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 2.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.7 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 1.5 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 1.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.3 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.1 | 1.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.4 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.5 | GO:1902001 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.1 | 0.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 1.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.2 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 1.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 1.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.2 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
0.1 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.2 | GO:0032892 | positive regulation of organic acid transport(GO:0032892) |
0.1 | 0.1 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.1 | 0.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.1 | 1.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 1.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 2.4 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.3 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.6 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.2 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.8 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.4 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 1.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.5 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.4 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 1.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 1.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.4 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 1.0 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.1 | 0.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 1.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 4.4 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.6 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.1 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 1.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.1 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.4 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.1 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.5 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.3 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.3 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.2 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 1.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.4 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 1.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.1 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.2 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 1.2 | GO:0001508 | action potential(GO:0001508) |
0.1 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 2.7 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.6 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.1 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.6 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.2 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.2 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.0 | 0.0 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.1 | GO:0048308 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) Golgi disassembly(GO:0090166) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.3 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) |
0.0 | 0.2 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.0 | 6.9 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.0 | 0.1 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.3 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 1.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.0 | 0.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.5 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.0 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.0 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.2 | GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) |
0.0 | 0.0 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 1.2 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.0 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.0 | 0.2 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.0 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.0 | 0.0 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.0 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.0 | 0.0 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.0 | 0.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.0 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.0 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.1 | 6.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.7 | 1.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.7 | 13.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.6 | 6.3 | GO:0044308 | axonal spine(GO:0044308) |
1.5 | 4.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.3 | 9.3 | GO:0033268 | node of Ranvier(GO:0033268) |
1.1 | 9.7 | GO:0005883 | neurofilament(GO:0005883) |
1.0 | 8.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.0 | 12.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.0 | 5.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.0 | 10.5 | GO:0030673 | axolemma(GO:0030673) |
0.9 | 7.4 | GO:0097449 | astrocyte projection(GO:0097449) |
0.9 | 5.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 4.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 2.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 5.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 4.9 | GO:0043203 | axon hillock(GO:0043203) |
0.8 | 14.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 3.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 39.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 16.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.7 | 3.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.7 | 9.3 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 12.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 17.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 1.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 6.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.6 | 17.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 3.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 4.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 5.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 4.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 3.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 6.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 1.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.4 | 21.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.4 | 1.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 13.6 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 0.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 1.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 2.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 2.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 1.7 | GO:0097433 | dense body(GO:0097433) |
0.3 | 3.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 1.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 35.4 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 4.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 0.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 2.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 3.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 35.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 5.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 0.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.3 | 1.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.3 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 2.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 3.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 2.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 0.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 13.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 4.8 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 2.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 2.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 8.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.2 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 2.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 3.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 18.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 4.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 8.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.7 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 16.7 | GO:0030424 | axon(GO:0030424) |
0.1 | 1.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 16.2 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 2.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 1.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 15.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 3.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 9.6 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 3.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 2.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.9 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 2.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 4.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 2.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.3 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.4 | GO:0031082 | BLOC complex(GO:0031082) |
0.0 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 3.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 23.0 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.0 | GO:0005767 | secondary lysosome(GO:0005767) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.6 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 1.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 1.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.3 | 21.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.1 | 6.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.1 | 6.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.8 | 14.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.8 | 5.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.7 | 5.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.7 | 6.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.6 | 4.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.5 | 7.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 7.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.4 | 11.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.4 | 4.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.4 | 9.5 | GO:0030957 | Tat protein binding(GO:0030957) |
1.3 | 6.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 3.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.2 | 4.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.2 | 3.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.1 | 4.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.0 | 3.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 6.2 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 4.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.0 | 3.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.0 | 1.0 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 9.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.0 | 4.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.9 | 3.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.9 | 0.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.9 | 10.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 11.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.8 | 3.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.8 | 2.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.8 | 2.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.8 | 1.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.8 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.8 | 0.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.8 | 3.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.8 | 2.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.8 | 0.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.7 | 4.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.7 | 3.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 9.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.7 | 6.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.6 | 4.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 15.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.6 | 3.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.6 | 4.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 5.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 2.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 4.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 2.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 17.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 1.5 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.5 | 2.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 2.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 9.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 1.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 1.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 2.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 1.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.5 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 1.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.5 | 2.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 2.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 4.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 0.9 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.4 | 2.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 3.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 1.7 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 9.4 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 1.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 7.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 5.3 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 4.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 1.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 6.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 5.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 2.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 4.7 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 5.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.4 | 1.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 2.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 1.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 10.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 4.3 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 1.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 0.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 8.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.3 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 9.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 7.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 2.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 1.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 1.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 3.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 4.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 5.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 2.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 0.6 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 0.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 11.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 1.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 4.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.3 | 1.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 6.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 0.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 0.3 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 1.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 0.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 1.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 2.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 2.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 4.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 2.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 2.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 2.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.0 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.2 | 3.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 3.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 1.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 1.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 3.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 3.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 5.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 4.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 4.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 0.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 5.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 3.7 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 1.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 3.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 3.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 2.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.4 | GO:0018649 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 3.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 6.7 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.2 | 1.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 3.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 1.1 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.2 | 3.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.3 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 2.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.2 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.6 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.2 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 3.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 2.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 3.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 3.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 1.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.3 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 1.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 0.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.8 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 7.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 2.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 2.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 2.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.6 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 1.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.3 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 6.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 2.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 4.8 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 1.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 2.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 2.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 1.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.5 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 3.6 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 2.4 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.1 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 2.4 | GO:0018031 | dihydrolipoamide branched chain acyltransferase activity(GO:0004147) palmitoleoyl [acyl-carrier-protein]-dependent acyltransferase activity(GO:0008951) serine O-acyltransferase activity(GO:0016412) O-succinyltransferase activity(GO:0016750) sinapoyltransferase activity(GO:0016752) O-sinapoyltransferase activity(GO:0016753) peptidyl-lysine N6-myristoyltransferase activity(GO:0018030) peptidyl-lysine N6-palmitoyltransferase activity(GO:0018031) benzoyl acetate-CoA thiolase activity(GO:0018711) 3-hydroxybutyryl-CoA thiolase activity(GO:0018712) 3-ketopimelyl-CoA thiolase activity(GO:0018713) N-palmitoyltransferase activity(GO:0019105) acyl-CoA N-acyltransferase activity(GO:0019186) protein-cysteine S-myristoyltransferase activity(GO:0019705) glucosaminyl-phosphotidylinositol O-acyltransferase activity(GO:0032216) ergosterol O-acyltransferase activity(GO:0034737) lanosterol O-acyltransferase activity(GO:0034738) naphthyl-2-oxomethyl-succinyl-CoA succinyl transferase activity(GO:0034848) 2,4,4-trimethyl-3-oxopentanoyl-CoA 2-C-propanoyl transferase activity(GO:0034851) 2-methylhexanoyl-CoA C-acetyltransferase activity(GO:0034915) butyryl-CoA 2-C-propionyltransferase activity(GO:0034919) 2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity(GO:0034945) L-2-aminoadipate N-acetyltransferase activity(GO:0043741) keto acid formate lyase activity(GO:0043806) azetidine-2-carboxylic acid acetyltransferase activity(GO:0046941) peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) acetyl-CoA:L-lysine N6-acetyltransferase(GO:0090595) |
0.1 | 0.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 2.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.5 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 1.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 10.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 1.4 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.6 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.3 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 1.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 1.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 2.4 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.6 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 2.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 5.9 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 1.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 1.6 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 1.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 1.3 | GO:0003729 | mRNA binding(GO:0003729) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 9.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 2.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 5.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 7.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 2.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 11.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 6.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 6.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 2.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 9.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 5.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 4.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 5.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 4.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 3.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 6.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 24.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 15.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 10.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.8 | 8.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 12.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 10.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.6 | 24.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 6.7 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.5 | 2.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 5.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 4.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 5.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 1.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 6.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 3.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 7.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 1.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 6.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 13.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 4.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 4.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 6.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 1.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 2.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 0.7 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.3 | 6.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 2.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 4.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 0.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 3.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 9.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 1.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 4.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 29.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 9.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 4.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 7.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 12.3 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.2 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 1.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 11.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 5.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 3.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.5 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.0 | 0.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 1.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 2.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.0 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |